Abrdn Life Sciences Investors HQL
Nov 3, 2026, 3:35 PM EST
- YTD
- +7.87%
- 1 year
- +5.85%
- Market cap
- 550.39M
- Revenue (ttm)
- 3.51M
- Profit margin
- 156.45%
- EPS (ttm)
- 6.64
- Shares out
- 28.06M
- P/E ratio
- 2.73
- Dividend
- 2.00 (11.95%)
- Ex-dividend date
- Nov 20, 2024
- YTD return
- +7.87%
- 1-year return
- +5.85%
- Volume
- 124.18K
- Avg volume
- 132.74K
- Open
- 17.85
- Previous close
- 17.98
- Day's range
- 17.91 – 18.29
- 52-week range
- 15.87 – 22.67
- Beta
- 0.70
2Y +3.39 (+23.05%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 107.60
- Price / book
- 0.84
- Dividend yield
- 14.12%
- Payout ratio
- 54.61%
- Revenue growth
- 7.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 1.28%
- Short % of float
- 0.00%
- 50-day average
- 14.47
- 200-day average
- 14.34
Next earnings
Consensus EPS estimate 0.00.
About Abrdn Life Sciences Investors
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
- Sector
- Financial Services
- Industry
- Asset Management
- Country
- United States
News
Analysis Of Abrdn Healthcare Investors (HQL): The Fund Is Currently Overvalued 
10 Best CEFs This Month: Average Yield Of 10% (September 2026) 
HQL: The Rally That Makes Growth Harder (Rating Downgrade) 
10 Best CEFs This Month: Average Yield Of Near 10% (August 2026) 
10 Best CEFs This Month: Average Yield Of Near 10% (July 2026) 
HQL: Attractive Outlook With Growth Of GLP-1 Market 
Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts 
How To Invest $100,000 Today: 5 Strategies For Success 
Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details 
10 Best CEFs This Month: Average Yield Of 10% (March 2026)
Your note
Sign in to keep a note on HQL — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DIMARTINO ROSE | Director | Purchase | Jul 15, 2024 | 1,000 |
| GOETZ KATHLEEN | Director | Purchase | Apr 8, 2024 | 1,085 |
| MAHER C WILLIAM | Director | Purchase | Aug 22, 2024 | 0 |
| OMSTEAD DANIEL R | President | Purchase | Sep 24, 2023 | 197,518 |
| REIT TODD | Director | Purchase | Jan 1, 2024 | 1,000 |
| SABA CAPITAL MANAGEMENT L P | Beneficial Owner of more than 10% of a Class of Security | Purchase | Jun 25, 2024 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Saba Capital Management, L.P. | 12.54% | 3,429,991 | 46.20M | Sep 29, 2024 |
| Penserra Capital Management LLC | 2.84% | 776,002 | 10.45M | Sep 29, 2024 |
| Morgan Stanley | 1.79% | 489,687 | 6.60M | Sep 29, 2024 |
| Karpus Management, Inc. | 1.71% | 468,598 | 6.31M | Sep 29, 2024 |
| SIT Investment Associates Inc | 1.52% | 417,064 | 5.62M | Sep 29, 2024 |
| Needham Investment Management, L.L.C. | 1.29% | 352,719 | 4.75M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Amplify High Income ETF | 2.83% | 774,198 | 10.43M | Sep 29, 2024 |
| Exchange Listed Fds Tr-Saba Closed-End Funds ETF | 0.98% | 268,088 | 3.61M | Aug 30, 2024 |
| Saba Capital Income & Opportunities Fund II | 0.47% | 128,601 | 1.73M | Jul 30, 2024 |
| AQR Funds-AQR Diversified Arbitrage Fd | 0.31% | 84,499 | 1.14M | Sep 29, 2024 |
| Saba Capital Income & Opportunities Fd | 0.14% | 37,835 | 509.64K | Jul 30, 2024 |
| First Trust Income Opportunity ETF | 0.05% | 13,358 | 179.93K | Oct 30, 2024 |